Hay fever is a common condition that is caused by an allergy to different types of pollen, according to the NHS. Pollen is a fine powder that is released by plants, and it contains proteins that can irritate the nose, throat and eyes. With around 20 per cent of the UK affected by hay fever, pollen count spikes could result in large numbers of runny noses and watering eyes. Most of the UK can expect ‘High’ levels of pollen today, according to the Met Office.
Hay fever patients can expect their symptoms to be worse today than any other day of the week forthcoming, it revealed.
Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.